Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer

NCT01263886

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Investigational Site Number 840001 Muscle Shoals, Alabama, United States
  • Investigational Site Number 840003 Hot Springs, Arkansas, United States
  • Investigational Site Number 840002 Anaheim, California, United States
  • Investigational Site Number 840009 Modesto, California, United States
View all 43 locations
View Trial Details
Completed

A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).

NCT01153399

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Athens, Greece
  • Research Site Crete, Greece
  • Research Site Ioannina, Greece
  • Research Site Kavala, Greece
View Trial Details
Completed

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

NCT00409188

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Saint Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Glendale Adventist Medical Center Glendale, California, United States
  • Norris Cancer Hospital Los Angeles, California, United States
View all 290 locations
View Trial Details
Completed

A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

NCT01121575

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Trials Office University of Colorado Hospital (CTO) Aurora, Colorado, United States
  • DRUG SHIPMENT: University of Colorado Cancer Center Aurora, Colorado, United States
  • Rocky Mountain Lions Eye Institute Aurora, Colorado, United States
  • University of Colorado Hospital Aurora, Colorado, United States
View Trial Details
Completed

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

NCT01924195

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing chest hospital，capital medical university Beijing, Beijing Municipality, China
  • Xinqiao Hospital, Third Military Medical University Chongqing, Chongqing Municipality, China
  • Hunan Province Tumor Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Completed

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

NCT00112346

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution Mobile, Alabama, United States
  • Local Institution Anchorage, Alaska, United States
  • Local Institution Bakersfield, California, United States
  • Local Institution Corona, California, United States
View all 38 locations
View Trial Details

Related conditions